Drug Type Small molecule drug |
Synonyms 2-(p-Aminophenyl)-2-ethylglutarimide, 3-Ethyl-3-(p-aminophenyl)-2,6-dioxopiperidine, Aminoglutethimide (USP/INN) + [9] |
Target |
Mechanism aromatase inhibitors(Aromatase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (29 Oct 1980), |
Regulation- |
Molecular FormulaC13H16N2O2 |
InChIKeyROBVIMPUHSLWNV-UHFFFAOYSA-N |
CAS Registry125-84-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00574 | Aminoglutethimide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Breast Cancer | CN | 01 Jan 1990 | |
Pituitary ACTH Hypersecretion | US | 29 Oct 1980 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Allergic asthma | Preclinical | US | 29 Apr 2013 | |
Peanut Hypersensitivity | Preclinical | US | 01 Feb 2013 |